Iovance Biotherapeutics Inc IOVA 深 滬
等待開盤 09-24 09:30:00 美东时间
10.19
-0.450
-4.23%
華盛通- 最 高10.845
- 今 開10.69
- 成交量 1591.73万股
- 最 低 10.12
- 昨 收 10.64
- 總市值 46.16亿
- 52周最高 10.98
- 市盈率 靜 --
- 換手率 3.51%
- 52周最低 1.76
- 委 比 -99.29%
- 總股本 4.53亿
- 歷史最高 54.208
- 量 比 0.83
- 振 幅 6.81%
- 歷史最低 1.6385
- 每 手 1
- 風險率 1.94%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics, Inc. announced on September 17, 2026, the grant of inducement stock options covering 179,750 shares of its common stock to eighteen new, non-executive employees. The options, granted under the Amended and Restated 2021 Inducement Plan, have an exercise price of $10.02 and vest over three years, with one-third vesting on the first anniversary of the employee’s start date and the remainder vesting quarterly over the next tw...
09-18 21:10
美股大行评级 | 赛富时获多家机构上调目标价，最高至300美元！谷歌获看多至450美元，仍有3成上涨空间
今日重点评级关注：Canaccord Genuity：维持Generac Holdings"买入"评级，目标价从275美元升至375美元；巴克莱：维持Oscar Health"超配"评级，目标价从39美元升至49美元
09-18 16:18
Barclays Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $15
Barclays analyst Etzer Darout maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight and raises the price target from $13 to $15.
09-17 20:17
The best Quant-rated stocks trading below $10 right now
Seeking Alpha's Quant Rating system has identified a fresh group of sub-$10 stocks that rank among the highest-rated names in its universe, underscoring that low-priced shares can still exhibit strong...
09-04 18:51
Iovance Biotherapeutics to Present at Upcoming Conferences
Iovance Biotherapeutics, Inc. announced that its senior leadership will present at the Wells Fargo 21st Annual Healthcare Conference on September 10, 2026, and the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The company, a leader in tumor infiltrating lymphocyte (TIL) therapies, developed Amtagvi® (lifileucel), the first FDA-approved one-time treatment for advanced melanoma. Live and archived webcasts of the pr...
09-04 12:00
Most shorted stocks on Wall Street
As September begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 44 stocks with short interest above 20% ...
09-02 22:28
美股大行评级 | 瑞杰金融维持英伟达"强力买入"评级，目标价从330美元升至352美元；瑞穗下调美光科技目标价从1375美元降至1300美元
今日重点评级关注：摩根大通：维持Ultragenyx Pharmaceutical"超配"评级，目标价从75美元升至80美元；瑞杰金融：维持英伟达"强力买入"评级，目标价从330美元升至352美元
08-26 08:37
TD Cowen Maintains Buy on Iovance Biotherapeutics, Raises Price Target to $10
TD Cowen analyst Nicholas Lorusso maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and raises the price target from $7 to $10.
08-25 22:01
Moderna(MRNA.US)mRNA癌症疫苗重大突破引爆市场情绪！生物科技板块估值重估可能才刚开始
生物科技行业在很大程度上受到临床事件的驱动——一项三期临床试验的成功或失败，不仅可以推动直接参与其中的公司股价大幅波动，也可能影响它们所代表的整个治疗技术类别...
08-25 11:45
Iovance Biotherapeutics Stock Is Trending Friday: What's Going On?
Shares of Iovance Biotherapeutics Inc. (NASDAQ:IOVA) are trending Friday morning, continuing a momentum surge that recently pushed the biotech stock to a new 52-week high after gaining over 250% year-to-date. Iovance Biotherapeutics stock is building positive momentum. Why is IOVA stock advancing? S...
08-21 22:07
